Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Videos|October 6, 2020
Loss and Managing the Crisis at Hand
Author(s)Joshua C. Morganstein, MD
If we acknowledge our feelings of grief and loss over the pandemic, we can begin to come together, encourage hope, find meaning, and stay connected. Dr Morganstein talks on this.
Advertisement
Dr Morganstein is Chair of the American Psychiatric Association Committee on the Psychiatric Dimensions of Disaster.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Comparison of Atypical Antipsychotics as Adjunctive Treatments for Major Depressive Disorder
2
Improving but Not Feeling It: Anticipatory Anhedonia and Cognition
3
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
4
Evidence-Based Ethical Principles for Long-Acting Injectable Antipsychotic Use
5